Event details

Put our diagnostics (Dx) team to work solving your challenge or improving your current workflow.


Sign up for our challenge, and you could get a 1-1 coaching session with our Dx team on customizing Whatman™ lateral flow pads and membranes or optimizing assay performance at in our Cytiva lab in Dassel, Germany*!


We are accepting applications that use a lateral-flow, flow-through, dipstick, or line blot platform from universities and companies (academic, start-ups, larger companies, and institutes) within EMEA and Asia pacific regions.


Select your research topic, register, and share your idea or project with us!


A panel of Cytiva judges will evaluate proposals based on relevance and potential for impact. Selected finalists will present to the panel, who will choose Dx Challenge winners from each region – EMEA and Asia Pacific.


Challenge winners will have the opportunity to collaborate alongside our experienced Dx team to bring their ideas to life. All finalists will have the ability to network with the team.


Submission period: 15 August – 30 December, 2022


*Terms and conditions apply. You may find more details in the section below.

Learn more


Thank you for your interest.


The registration period for the Immunoassay Rapid Test Challenge is now closed.


Feel free to reach out to [email protected] if you have any enquiries regarding your submission for the Immunoassay Rapid Test Challenge.


Panel 2 header

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Repellendus aliquid tempore natus voluptates repudiandae, eos dolorem libero inventore, quod incidunt, asperiores. Reiciendis itaque enim pariatur, blanditiis minima autem quo a nulla, obcaecati quis, excepturi atque ab rerum! Sequi molestias vel eum, hic, perspiciatis eius suscipit reprehenderit molestiae vitae similique.

Learn more


About Cytiva Immunoassay Rapid Test Challenge

Learn more

We welcome innovative solutions with the potential to support disease identification and development of targeted therapies for precision health or improvement in rapid point-of-care immunodiagnostics tests.

This challenge is an open call for projects from universities and companies (academic, start-ups, larger companies, and institutes) within EMEA and Asia Pacific regions. Applicants must agree to provide Cytiva with the permission to publish research findings from the submitted proposal and have the ability and interest to travel to our Diagnostic lab in EMEA (Dassel) or within Asia Pacific 1.

Have questions? Please contact us before applying.

1Depending on the COVID-19 pandemic and individual country’s travel restriction, visit to Cytiva Diagnostic lab may be subject to change for winners based within EMEA or Asia Pacific regions. Confirmation of the lab site visit will be announced together with the announcement of winner on 10 February, 2023.

Fill in your details in the registration form on this page.

  • The project must be innovative, developing a test for which there is no simple test kit commercially available.
  • The project must not have been submitted or shared with Cytiva before or via other previous Cytiva challenges.
  • You must be willing to use Whatman™ filter papers or membranes in the research findings.
  • Products used in the submitted research must be purchased from Cytiva or our approved distributors. Our Cytiva representatives will also reach out to you to support and ensure that you have the right materials for your research after registration.
Immunoassay Rapid Test Challenge Guidelines

Share these details about your idea or project:

  • What is the target molecule(s) to be detected?
  • Tell us about the sample type being analyzed.
  • What is the current method to detect the molecule? (LFA, Flow through, etc.).
  • Why is it important to improve your rapid test?
  • How do you expect the use of Whatman™ filter paper or membranes will help to improve the overall workflow in terms of sensitivity and performance?
  • What is your previous experience with this/these specific target molecule(s)?
  • What are your ideas for commercialization of the test: potential market size, end-users?

Klaus Hochleitner PhD
Global Product Specialist

Dr. Klaus Hochleitner is a recognized global expert in membrane-based detection and analysis systems. He has published extensively and is in demand as a speaker on this topic.

Klaus is currently Global Product Specialist for Diagnostics at Cytiva. In this position, he focuses on teaching, training, and supporting diagnostic rapid test developers and manufacturers, sharing his expertise on the materials and methods to develop and produce diagnostic systems.




Lee Jenkins
Senior Product Manager

Lee is part of the Senior Management team within the Whatman business area of Cytiva, with overall responsibility for the performance of a large portfolio of products and services, primarily focused on the diagnostic rapid testing market.

He has experience of involvement with diagnostic development companies for over 5 years and part of the Cytiva (formerly GE Life Sciences) business for over 9 years.

This challenge focuses on immunoassay applications which uses lateral-flow, flow-through, dipstick or line blot platform.

This Cytiva Immunoassay Rapid Test Challenge is open to EMEA and Asia Pacific corporations and research institutions.

Challenge entry runs from 15 August to 30 December, 2022.

Winners will be announced on 10 Februay, 2023.

The coaching session must take place before 29 March, 2023 either virtually or onsite, but arrangement of the coaching session has to be confirmed with Cytiva before 24 February, 2023.

Prior to applying, please read the full terms and conditions of the Challenge which can be found via this link.

1st – One (1) selected winner1 from EMEA and one (1) from Asia Pacific region will receive a 3-day coaching on assay development with a Cytiva Dx team member in our Cytiva lab in Dassel, Germany2 or remotely.

2nd – Two (2) selected winners from EMEA and two (2) from Asia Pacific region will have a one-to-one virtual coaching session3 with a Cytiva Dx team member on assay development.


1If selected winner comprises more than 1 individual, winner can only send 1 representative to receive the 3-day coaching on assay development with a Cytiva Dx team member in our Cytiva lab at Dassel, Germany physically.

2Cytiva (Sponsor) will only cover the economy class travel cost, business class accommodation for 3 days 2 nights, local transfers and transportation of materials to/from the Cytiva site by the representative of the final winner. Any additional costs will be the responsibility of the final winner (Entrant). All travel and accommodation will be arranged through an approved Cytiva travel agent. Arrangement of coaching session (including booking of flight and accommodation) with Cytiva Dx team in our Cytiva lab at Dassel, Germany will have to be confirmed before 24 February, 2023 and coaching session must be completed before 29 March, 2023.

3Virtual coaching session with a Cytiva Dx team member must take place before 29 March, 2023, but arrangement of coaching session has to be confirmed with Cytiva before 24 February, 2023.


Follow our connected mAb perfusion process

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don't look even slightly believable. If you are going to use a passage of Lorem Ipsum, you need to be sure there isn't anything embarrassing hidden in the middle of text.

All the Lorem Ipsum generators on the Internet tend to repeat predefined chunks as necessary, making this the first true generator on the Internet. It uses a dictionary of over 200 Latin words, combined with a handful of model sentence structures, to generate Lorem Ipsum which looks reasonable. The generated Lorem Ipsum is therefore always free from repetition, injected humour, or non-characteristic words etc.

Latest video


About Cytiva
 

Did you know that Cytiva offers services that span from component customization to complete development of your molecular or immunodiagnostic assay from idea to commercialization? So, if you are looking to customize Whatman™ lateral flow pads and membranes or optimize the performance of magnetic beads, we can help you to accelerate the launch of your diagnostic assay. We work with complete transparency and empower you to solve challenges, too.

Klaus Hochleitner PhD
Cytiva panelist
Klaus Hochleitner PhD

Dr. Klaus Hochleitner is a recognized global expert in membrane-based detection and analysis systems. He has published extensively and is in demand as a speaker on this topic.

Klaus is currently Global Product Specialist for Diagnostics at Cytiva. In this position, he focuses on teaching, training, and supporting diagnostic rapid test developers and manufacturers, sharing his expertise on the materials and methods to develop and produce diagnostic systems.

Connecting the dots - Introduction
Cytiva panelist
Lee Jenkins

Lee is part of the Senior Management team within the Whatman business area of Cytiva, with overall responsibility for the performance of a large portfolio of products and services, primarily focused on the diagnostic rapid testing market.

He has experience of involvement with diagnostic development companies for over 5 years and has been part of the Cytiva business for over 9 years.


Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .

Publish date: 29 September, 2020

Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .

Publish date: 29 September, 2020

Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .

Publish date: 29 September, 2020

Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .

Publish date: 29 September, 2020

Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .

Publish date: 29 September, 2020

Curious about continuous biomanufacturing? Join the Cytiva project team vlog series as we document our proof of concept trial and provide insights to help you efficiently plan and execute your project .

Publish date: 29 September, 2020
About Cytiva
Did you know that Cytiva offers services that span from component customization to complete development of your molecular or immunodiagnostic assay from idea to commercialization?


So, if you are looking to customize Whatman™ lateral flow pads and membranes or optimize the performance of magnetic beads, we can help you to accelerate the launch of your diagnostic assay. We work with complete transparency and empower you to solve challenges, too.

Tab 2 Heading
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis commodo nisi ac elementum ultrices. Curabitur sollicitudin gravida ante vitae blandit. Vivamus eros eros, semper eget sapien vel, bibendum ultricies diam. Ut et diam neque. Ut velit enim, egestas at tortor ut, sagittis suscipit lacus. Morbi eleifend ultricies magna, at aliquam nisi. Sed faucibus nunc vel semper rutrum. Donec sit amet venenatis metus. Cras eget commodo ligula. Etiam vulputate arcu et velit iaculis, sed semper dui molestie. Morbi eget convallis ligula, a venenatis nisl. Cras imperdiet elementum venenatis. Quisque eu dolor hendrerit augue luctus tempus sed sit amet magna.
Tab 3 Heading
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis commodo nisi ac elementum ultrices. Curabitur sollicitudin gravida ante vitae blandit. Vivamus eros eros, semper eget sapien vel, bibendum ultricies diam. Ut et diam neque. Ut velit enim, egestas at tortor ut, sagittis suscipit lacus. Morbi eleifend ultricies magna, at aliquam nisi. Sed faucibus nunc vel semper rutrum. Donec sit amet venenatis metus. Cras eget commodo ligula. Etiam vulputate arcu et velit iaculis, sed semper dui molestie. Morbi eget convallis ligula, a venenatis nisl. Cras imperdiet elementum venenatis. Quisque eu dolor hendrerit augue luctus tempus sed sit amet magna.
Tab 4 Heading
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis commodo nisi ac elementum ultrices. Curabitur sollicitudin gravida ante vitae blandit. Vivamus eros eros, semper eget sapien vel, bibendum ultricies diam. Ut et diam neque. Ut velit enim, egestas at tortor ut, sagittis suscipit lacus. Morbi eleifend ultricies magna, at aliquam nisi. Sed faucibus nunc vel semper rutrum. Donec sit amet venenatis metus. Cras eget commodo ligula. Etiam vulputate arcu et velit iaculis, sed semper dui molestie. Morbi eget convallis ligula, a venenatis nisl. Cras imperdiet elementum venenatis. Quisque eu dolor hendrerit augue luctus tempus sed sit amet magna.

Form title

Form sub title